Literature DB >> 23678221

Cardiac amyloidosis presenting with prolonged QT interval and recurrent polymorphic ventricular tachycardia.

Nisha A Gilotra1, Grant V Chow, Oscar H Cingolani.   

Abstract

Cardiac amyloidosis results in severely symptomatic heart failure that has a poor prognosis because of the development of a restrictive cardiomyopathy. The diagnosis of cardiac amyloidosis is often delayed because of nonspecific signs and symptoms. We report the case of a 66-year-old woman who had been diagnosed with sick sinus syndrome and presented 5 months later with a long QT interval and recurrent polymorphic ventricular tachycardia. The diagnosis of cardiac amyloidosis was confirmed upon analysis of endomyocardial biopsy results. The patient was subsequently diagnosed with and treated for underlying plasma cell myeloma and later died of cardiac arrest. This atypical presentation of cardiac amyloidosis underscores the need to consider it in the differential diagnosis of patients who have ventricular arrhythmias. To our knowledge, the combination of long QT interval and polymorphic ventricular tachycardia has not been previously reported in association with amyloid heart disease.

Entities:  

Keywords:  Amyloidosis/complications/diagnosis/etiology; cardiomyopathies/diagnosis/therapy; diagnosis, differential; tachycardia, ventricular/etiology/therapy

Mesh:

Year:  2013        PMID: 23678221      PMCID: PMC3649786     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  3 in total

Review 1.  Amyloid diseases of the heart: assessment, diagnosis, and referral.

Authors:  S W Dubrey; P N Hawkins; R H Falk
Journal:  Heart       Date:  2011-01       Impact factor: 5.994

2.  Focal monomorphic ventricular tachycardia as the first manifestation of amyloid cardiomyopathy.

Authors:  Srikanth Seethala; Sandeep Jain; N Paul Ohori; Sara Monaco; Joan Lacomis; Frederick Crock; Jan Nemec
Journal:  Indian Pacing Electrophysiol J       Date:  2010-03-05

Review 3.  Cardiac amyloidosis treated with an implantable cardioverter defibrillator and subcutaneous array lead system: report of a case and literature review.

Authors:  Abhijeet Dhoble; Atul Khasnis; Adesuwa Olomu; Ranjan Thakur
Journal:  Clin Cardiol       Date:  2009-08       Impact factor: 2.882

  3 in total
  4 in total

1.  Cardiac Amyloidosis, An Infiltrative Heart Disease Presenting as Arrhythmia-A Case Report.

Authors:  B Magesh; Deepak Kadeli; Sunil Bohra; V Krishnaprasath; R Keshava
Journal:  J Clin Diagn Res       Date:  2017-04-01

2.  A Case Report of Sick Sinus Syndrome as an Initial Presentation of Primary Amyloidosis.

Authors:  Basel Abdelazeem; Bilal Malik; Nischit Baral; Rudin Gjeka; Arvind Kunadi
Journal:  Cureus       Date:  2021-03-16

Review 3.  Handling of Ventricular Fibrillation in the Emergency Setting.

Authors:  Zoltán Szabó; Dóra Ujvárosy; Tamás Ötvös; Veronika Sebestyén; Péter P Nánási
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

4.  Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities.

Authors:  Michele Orini; Adam J Graham; Ana Martinez-Naharro; Christopher M Andrews; Antonio de Marvao; Ben Statton; Stuart A Cook; Declan P O'Regan; Philip N Hawkins; Yoram Rudy; Marianna Fontana; Pier D Lambiase
Journal:  J Am Heart Assoc       Date:  2019-09-08       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.